Onderneming Anebulo Pharmaceuticals, Inc.
Aandelen
ANEB
US0345691036
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,12 USD | +5,41% | +11,65% | +28,93% |
Vakgebied
Aantal werknemers: 2
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Lawler
FOU | Founder | 52 | 23-04-20 |
Chief Executive Officer | 54 | 05-10-23 | |
Daniel George
DFI | Director of Finance/CFO | 54 | 28-09-23 |
Kenneth Cundy
CTO | Chief Tech/Sci/R&D Officer | 65 | 20-05-22 |
Madison Damour
IRC | Investor Relations Contact | - | - |
Scott Anderson
IRC | Investor Relations Contact | - | 06-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Aryeh
BRD | Director/Board Member | 56 | 01-03-21 |
Kenneth Lin
BRD | Director/Board Member | 51 | 01-02-21 |
Bimal Shah
BRD | Director/Board Member | 48 | 05-10-23 |
Chief Executive Officer | 54 | 05-10-23 | |
Director/Board Member | 42 | 01-11-22 | |
Karah Parschauer
BRD | Director/Board Member | 46 | 01-02-21 |
Joseph Lawler
FOU | Founder | 52 | 23-04-20 |
Aron English
BRD | Director/Board Member | 41 | 01-06-20 |
Areta Kupchyk
BRD | Director/Board Member | 67 | 01-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 933 217 | 8 978 689 ( 34,62 %) | 0 | 34,62 % |
Bedrijfsgegevens
Anebulo Pharmaceuticals, Inc.
1017 Ranch Road 620 South Suite 107
78734, Lakeway
+(512) 598-0931
http://www.anebulo.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,93% | 76,76 mln. | |
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |
- Beurs
- Aandelen
- Koers ANEB
- Onderneming Anebulo Pharmaceuticals, Inc.